Collectively, these data suggest that transcription of HERVs and other LTR elements that are highly specific to ccRCC were overexpressed in non-responders pre-treatment and were associated with an absence of ongoing anti-tumor immune responses and lack of response to anti-PD-1. This evidence concerns the gene PDCD1 and nonpapillary renal cell carcinoma.